Icu Medical Inc (ICUI) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Sep 3, 2026.

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free
Filings shown
8
Open-market buys
0
Open-market sells
14

Counts cover the 8 most recent Form 4 filings Tradune holds for ICUI (filed May 22 – Sep 3, 2026); the score below covers only the trailing 90 days (0 buys, 13 sells). No completed check of ICUI's Form 4 list on SEC EDGAR is on record yet; the latest ICUI filing Tradune holds was filed Sep 3, 2026. This is not guaranteed to be the complete record — see ICUI's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 7 filings Tradune holds for ICUI filed Aug 11 – Sep 3, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

13 open-market sales by Rule 10b5-1 checkbox

On filings with the 10b5-1 box checked
9 sales· 20,544 sh
checkbox disclosed
On filings with the box not checked
4 sales· 16,974 sh
not proof that no plan exists
Not comparable
0 sales· 0 sh
filed before Apr 1, 2023, or no checkbox value in the filing data

Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
Brian Michael BonnellChief Financial Officer 0 5 — 15,688 −$2,724,818
Virginia Ruth SanzoneVP, General Counsel 0 4 — 4,856 −$819,150
Christian B. VoigtlanderChief Operating Officer 0 1 — 8,929 −$1,633,404
Daniel WoolsonVP, GM-Infusion Capital 0 1 — 5,417 −$982,265
Ben SousaChief Information Officer 0 1 — 2,250 −$401,209
Elisha W. FinneyDirector 0 1 — 378 −$68,978

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score
0/ 100
Net insider sales
0 distinct buyers0 buy · 13 sell tx

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at ICUI

No open-market insider purchases (Form 4 code P) were reported for ICUI between May 22, 2026 and Sep 3, 2026. The filings below may include other transaction types — sales, grants, option exercises, and tax withholding — shown for completeness; they are not open-market purchases.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

Virginia Ruth Sanzone VP, General Counsel · filed Sep 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 2,202 $167.67 17,258 −11% Sep 3, 2026
Open-market sale 10b5-1 box checked 1,238 $168.44 16,020 −7.2% Sep 3, 2026
Open-market sale 10b5-1 box checked 724 $169.53 15,296 −4.5% Sep 3, 2026
Open-market sale 10b5-1 box checked 692 $171.52 14,604 −4.5% Sep 3, 2026

† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.

“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.

Brian Michael Bonnell Chief Financial Officer · filed Sep 1, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 6,381 $175.00 56,062 −10% Sep 1, 2026
Brian Michael Bonnell Chief Financial Officer · filed Aug 31, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 1,712 $171.05 70,038 −2.4% Aug 31, 2026
Open-market sale 10b5-1 box checked 1,914 $172.12 68,124 −2.7% Aug 31, 2026
Open-market sale 10b5-1 box checked 4,568 $173.44 63,556 −6.7% Aug 31, 2026
Open-market sale 10b5-1 box checked 1,113 $173.91 62,443 −1.8% Aug 31, 2026
Daniel Woolson VP, GM-Infusion Capital · filed Aug 13, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 5,417 $181.33 17,062 −24% Aug 13, 2026
Ben Sousa Chief Information Officer · filed Aug 12, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 2,250 $178.32 3,076 −42% Aug 12, 2026
Christian B. Voigtlander Chief Operating Officer · filed Aug 11, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 8,929 $182.93 37,377 −19% Aug 11, 2026
Elisha W. Finney Director · filed Aug 11, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 378 $182.48 4,871 −7.2% Aug 11, 2026
Daniel Woolson President · filed May 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 2,123 $132.21 22,479 −8.6% May 22, 2026

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to ICUI's (Sep 3, 2026).

Frequently asked about ICUI insider activity

How many insiders bought ICUI stock in these Form 4 filings?

No open-market purchases (Form 4 code P) of ICUI shares were reported by Icu Medical Inc insiders between May 22, 2026 and Sep 3, 2026. The 8 filings shown on this page cover other transaction types — sales, grants, option exercises, and tax withholding.

Who filed the most recent Form 4 for ICUI?

The most recent Form 4 on this page was filed by Virginia Ruth Sanzone (VP, General Counsel) on Sep 3, 2026, reporting 4 transactions. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market ICUI insider sale shown?

The largest open-market sale among the filings shown was 8,929 ICUI shares at $182.93 (about $1,633,404) by Christian B. Voigtlander (Chief Operating Officer) on Aug 11, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for ICUI — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

Track ICUI insider filings free →

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.